Michael John Millan

Title: Michael John Millan: Innovator in Pharmaceutical Chemistry

Introduction

Michael John Millan is a notable inventor based in Tonbridge, GB. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 5 patents. His work primarily focuses on the development of innovative compounds that have potential applications in medicine.

Latest Patents

Among his latest patents is the invention of crystalline complexes of fluticasone-2-furoate. This patent describes a crystalline complex comprising a compound of formula (I), where the crystal lattice is stabilized by the presence of a guest molecule. The crystalline complex is characterized by a space group P222, with unit cell dimensions of about 12.5±1.0 Å, 15±1.0 Å, and 16.2±1.0 Å when determined at either 120K or 150K. Another significant patent is for 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione mesylate salt. This patent discloses mesylate salts or solvates of the compound, along with processes for preparing such compounds, their compositions, and their use in medicine.

Career Highlights

Michael has worked with prominent companies in the pharmaceutical industry, including SmithKline Beecham Corporation and Glaxo Group Limited. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Michael has collaborated with notable colleagues such as Andrew Simon Craig and Keith Biggadike. These partnerships have likely enhanced his research and development efforts in the pharmaceutical sector.

Conclusion

Michael John Millan is a distinguished inventor whose work in pharmaceutical chemistry has led to several important patents. His contributions continue to impact the field and advance medical science.